Lawrence Steinman

Lawrence Steinman

Fortune : 180 262 $ au 31/08/2026

78 ans
Health Technology
Consumer Services
Commercial Services

Profil

Lawrence J.
Steinman
founded Nuon Therapeutics, Inc. in 2006, Neurocrine Biosciences, Inc. in 1997, where he worked as Director from 1997 to 2005, Bayhill Therapeutics, Inc. in 2001, where he worked as Director from 2010 to 2013, Atreca, Inc. in 2012, where he worked as Director from 2012 to 2019, Forum Markets, Inc. in 2013, where he worked as Director from 2024 to 2025, and Pasithea Therapeutics Corp.
in 2020, where he is working as Executive Chairman.
Dr. Steinman also founded Drumroll Health, Inc., Steinman Laboratory, Katexco Pharmaceuticals Corp., where he is working as Chairman, and Tolerion, Inc., where he worked as Executive Chairman from 2013 to 2020.
Dr. Steinman also currently works at CannBioRex Pharmaceuticals Corp., as Co-Chairman from 2018, 180 Life Corp., as Co-Chairman from 2019, BioAtla, Inc., as Lead Independent Director from 2020, Himalaya Therapeutics, as Director, National Academy of Sciences, as Member, National Academy of Medicine (United States), as Member, Pharnext SA, as Member-Supervisory Board from 2023, and Stanford University, as Professor from 2011.
Dr. Steinman also formerly worked at KBL Merger Corp.
IV, as Co-Executive Chairman, Stanford University School of Medicine, as Chairman-Interdepartmental Program from 2003 to 2011, Centocor, Inc., as Director from 1990 to 1998, and Neuronyx, Inc., as Director.
Dr. Steinman received his undergraduate degree in 1968 from Dartmouth College, doctorate degree in 2008 from Hasselt University, doctorate degree in 1973 from Harvard Medical School, and doctorate degree in 2022 from the University of Buenos Aires School of Medicine.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
24/07/2026 199 691 ( 0,6 % ) 114 623 $ 31/08/2026
12/07/2025 11 249 ( 0,09 % ) 63 782 $ 31/08/2026
18/05/2026 1 099 ( 0,07 % ) 1 857 $ 31/08/2026

Postes actifs de Lawrence Steinman

SociétésPosteDébut
BIOATLA, INC. Directeur/Membre du Conseil 01/07/2020
PHARNEXT SCA Directeur/Membre du Conseil 17/07/2020
PASITHEA THERAPEUTICS CORP. Fondateur 12/05/2020
Fondateur -
Corporate Officer/Principal 01/01/2001
Directeur/Membre du Conseil -
Président 14/05/2019
Corporate Officer/Principal -
Corporate Officer/Principal -
░░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░ ░░░░░░░░░░ ░░░░░░░░░░

Anciens postes connus de Lawrence Steinman

SociétésPosteFin
░░░░░ ░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░ ░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Lawrence Steinman

Formation de Lawrence Steinman

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

73

Relations au 1er degré

26

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées26

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Consumer Services

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Consumer Services

Finance

Commercial Services

Health Technology

Steinman Laboratory

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

  1. Bourse
  2. Insiders
  3. Lawrence Steinman
-40% : Prolongation exceptionnelle ➤➤➤➤
j
:
:
PROFITEZ-EN MAINTENANT
🔇